|
Vinvesting.com is the leading website for value investors where you can get the latest investment ideas, insights and interviews from great investors like Warren Buffett, Templeton etc. Over the last 70 years, value stocks clocked a 13.4% average annual return, vs. 10.2% for growth stocks, according to Ibbotson Associates. |
Archives
By admin - Posted on September 5th, 2008
Jason Ronovech is feeling good about health-care stocks. The co-manager with Jonathan Vyorst of Paradigm Value Fund (PVFAX) is finding that the health-care sector holds plenty of the out-of-favor, undervalued companies he seeks.
Health care had lagged the U.S. market, but the fund managers took a contrarian view; about 13% of the small-cap value fund was recently committed to the sector. The strategy has been rewarding lately, as health-care stocks have rebounded.
- Add new comment
- Read more
Jason Ronovech is feeling good about health-care stocks. The co-manager with Jonathan Vyorst of Paradigm Value Fund (PVFAX) is finding that the health-care sector holds plenty of the out-of-favor, undervalued companies he seeks.
Health care had lagged the U.S. market, but the fund managers took a contrarian view; about 13% of the small-cap value fund was recently committed to the sector. The strategy has been rewarding lately, as health-care stocks have rebounded.
- Add new comment
- Read more
By admin - Posted on September 5th, 2008
Tagged: The transcript of the Ruane, Cunniff & Goldfarb Investor Day 2008 annual meeting held in St. Regis Hotel, New York City has been released.
The transcript of the Ruane, Cunniff & Goldfarb Investor Day 2008 annual meeting held in St. Regis Hotel, New York City has been released.
By admin - Posted on September 5th, 2008
Tagged: Everyone has heard the theory that no investor can expect to consistently beat the market over the long term; the stock market today is simply too efficient. Of course, in most cases this sentiment is correct; it is exceedingly difficult to be on the right side of the market year after year. However, there are exceptions to every rule and one exception to this investment adage is Leucadia National Corp. (LUK). To be fair, LUK does not outpace the market every year, but over the long haul its performance is undeniable.
Everyone has heard the theory that no investor can expect to consistently beat the market over the long term; the stock market today is simply too efficient. Of course, in most cases this sentiment is correct; it is exceedingly difficult to be on the right side of the market year after year. However, there are exceptions to every rule and one exception to this investment adage is Leucadia National Corp. (LUK). To be fair, LUK does not outpace the market every year, but over the long haul its performance is undeniable.
By admin - Posted on September 5th, 2008
Hansen Natural (HANS) is one of the best stock stories of the past 10 years. As with all growth stocks though, Hansen has come crashing back to earth. These are the times when these rocket growth stocks become attractive to value investors like us. Hansen won't come close to it's 5 year figures of 48% annual revenue growth and 92% operating earnings growth, but the latest quarter showed a company that is still growing. Let's look a bit closer.
Read more ...
Hansen Natural (HANS) is one of the best stock stories of the past 10 years. As with all growth stocks though, Hansen has come crashing back to earth. These are the times when these rocket growth stocks become attractive to value investors like us. Hansen won't come close to it's 5 year figures of 48% annual revenue growth and 92% operating earnings growth, but the latest quarter showed a company that is still growing. Let's look a bit closer.
Read more ...
